We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Oxycodone, hydrocodone, fentanyl and morphine products accounted for less than 25 percent of opioids sold between 1992 and 1995, but reached an 80 percent share by 2011. Read More
Opioid sales increased more than eightfold between 1992 and 2015, according to a new analysis by the FDA that found no clear links between price and volume. Read More
The state declined to refund the federal share of ineligible claims and said all rebate-eligible drugs would be properly invoiced eventually. Read More
A federal judge overturned a $2.5 billion patent infringement verdict, the largest ever in a U.S. patent case, against Gilead Sciences in a dispute with Merck. Read More
Allergan agreed to pay a class of doctors $13.45 million over claims the company artificially maintained the price of Botox through a deal with a potential competitor. Read More